A pile of soon-to-expire FSA cash is a peculiar sales catalyst, but Polsen Health has found one. The Amsterdam-based preventative-health wearable company is partnering with Flex to let customers pay for every Polsen watch and strap using eligible HSA or FSA funds at checkout. No reimbursement chase, no claim forms, and buyers can split the cost with another card. For a young consumer-health brand, removing that payment friction may matter more than another glossy hardware feature.
Pre-Tax Convenience Meets a Crowded Wearables Market
Polsen is not merely slapping an eligible-payment badge onto a gadget. Its pitch is a screenless wearable with a free app and no recurring subscription. That is a meaningful distinction in a category that has trained consumers to expect an ongoing fee after buying the hardware. The company says its watches monitor overnight heart-rate variability, minute-by-minute heart rate, resting heart rate, temperature, menstrual cycle, sleep and steps. Its Reactivity Monitor reads heart rate every second to map changes in autonomic nervous-system activity.
Those are ambitious features, and prospective buyers should still treat wearable data as information rather than diagnosis. But the commercial logic is clean enough: Polsen wants to frame long-term pattern tracking, stress awareness and guided breathwork as a preventative-health purchase rather than a discretionary accessory. Flex gives that framing a payment rail built specifically for eligible health spending.
The Year-End Balance Problem Is Real
The timing is no accident. Polsen points to roughly half of FSA holders forfeiting unused money in 2022, with an average loss of $441. Many FSA balances face a December 31 expiration, although individual employer plans can have different carryover or grace-period rules. That wrinkle matters. Still, the broader behavior is familiar: people scramble late in the year to use funds, and brands that offer a simple eligible checkout can catch that demand without cutting the sticker price.
Flex says it supports more than 1,000 wellness brands and is working to unlock a pool of more than $150 billion in annual pre-tax HSA and FSA spending. Big number, naturally, but investors should not confuse the size of the pool with revenue available to any one brand. Eligibility, awareness, product price, employer-plan rules and consumer trust all stand between that $150 billion figure and an actual Polsen sale. The opportunity is attractive; the conversion math remains unproven.
Subscription-Free Is the Sharp End of Polsen's Pitch
What I find more interesting than the checkout integration is the company’s refusal to put its insights behind a recurring paywall. Hardware makers love subscriptions because they smooth revenue and can fatten lifetime value. Customers, meanwhile, are getting downright tired of buying a device and then renting access to their own information. Polsen says its health data is never monetized, its insights are never paywalled, and it manufactures in-house across Europe. Those are costly promises to keep, but they could separate the brand if consumers believe them.
There is a trade-off hiding in plain sight. Without subscription revenue, Polsen has to earn enough on the initial device sale, accessories and repeat purchases to fund software development, support, compliance and hardware iteration. The Flex arrangement could help by bringing pre-tax dollars into the first transaction and making a higher-priced device feel less painful. It does not magically solve the economics of consumer electronics.
Prevention Is a Strong Theme, Not a Guaranteed Outcome
Polsen’s broader rationale rests on a serious public-health backdrop. It cites CDC data that more than three in four American adults live with at least one chronic condition, while chronic disease drives much of the nation’s $5.3 trillion in annual health-care spending. That scale is grim, and it explains why prevention has become a magnet for wearable companies. Earlier visibility into habits, sleep, stress and recovery could encourage useful conversations or behavior changes before people feel unwell.
Yet this sector has a bad habit of outrunning its evidence. A stream of biometric readings can be helpful, but it can also create noise and anxiety if the product nags users over every imperfect night. Polsen’s management says the device stays quiet and highlights sustained patterns rather than a single sleep score. That is exactly the right philosophy, assuming execution matches the marketing.
What Deserves Attention From Here
- Whether HSA/FSA eligibility lifts conversion around year-end rather than merely shifting existing buyers to a different card.
- Whether the no-subscription model creates enough gross profit to support a durable product business.
- Whether users find the screenless, low-interruption approach more trustworthy than engagement-driven wearable apps.
- Whether Flex’s established wellness network gives Polsen meaningful discovery or just smoother payment processing.
This is not a blockbuster announcement, and that is fine. It is a practical distribution move in a market where practical details decide plenty of purchases. Polsen has paired a clear consumer annoyance—unused pre-tax balances—with a clear category annoyance—subscription fatigue. If the company can turn that tidy pitch into repeatable demand without overselling what its data can do, this partnership has more substance than the usual wellness-tech confetti.